Business

License agreement between Nencki Institute and Teldoc Sp. z o. o.

03.09.2021

On August 31, 2021, prof. Agnieszka Dobrzyn, Nencki Institute’s Director, and Ms. Marta Kaleńska-Jaśkiewicz, Chief Executive Officer of Teldoc Sp. z o. o., signed a license agreement that defines the framework for Teldoc's use of the know-how and the IT system, which were developed within SONAR projects (SONAR system). SONAR system is a combination of a group testing strategy for SARS-CoV-2 diagnosis and an IT tool, which significantly improves practical implementation of the diagnostic ...

European patent granted for an invention from Nencki Institute and IIMCB

20.08.2021

The European Patent Office has issued a decision to grant a patent for an invention entitled “microRNA biomarkers in blood for diagnosis of Alzheimer's Disease” (EP3449009). The document claims a ...

Research and development collaboration between Nencki Institute and Pikralida Sp. z o. o., to treat epileptogenesis

13.07.2021

Nencki Institute and Pikralida Sp. z o. o. collaborate on „Use of matrix metalloproteinase inhibitor to develop an innovative therapy of preventing the development of post-traumatic and ...

Collaboration Agreement between Nencki Institute and Thereson S.r.l.

09.07.2021

Nencki Institute PAS has entered a research collaboration with Thereson, a company focusing on therapeutic magnetic resonance. Laboratory of Mitochondrial Biology and Metabolism, led by ...

SPARK Europe Webinar

17.03.2021

Nencki Institute as a representative of SPARK Poland within the SPARK Europe would like to cordially invite you to participate in the next webinar of European SPARKs joint series on March 24th, ...